Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence

@article{Bach2001ManagementOA,
  title={Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Summary and Appraisal of Published Evidence},
  author={Peter B. Bach and C D Brown and Sarah E Gelfand and Douglas C Mccrory},
  journal={Annals of Internal Medicine},
  year={2001},
  volume={134},
  pages={600-620}
}
The primary aims of this paper are 1) to summarize and evaluate published data that address care of patients with acute exacerbations of chronic obstructive pulmonary disease [COPD] and 2) to improve the care that these patients receive by identifying efficacious and inefficacious treatment strategies. This paper provides the background evidence for the clinical practice guideline in this issue (see pages 595-599). A joint panel from the American College of PhysiciansAmerican Society of… 
An update on chronic obstructive pulmonary disease.
  • R. Pleasants, D. Haden
  • Medicine
    The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists
  • 2005
TLDR
Pharmacists can assist in proper drug selection and administration in COPD patients in long-term care facilities, in addition to preventing complications of drug therapy such as steroid-induced osteoporosis.
Approach to chronic obstructive pulmonary disease in primary care.
TLDR
An evidence-based approach to managing COPD along with a primary care chronic disease management model could improve quality of life for patients with COPD.
Quality of Care for Patients Hospitalized for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
TLDR
The quality of care provided to patients hospitalized for acute exacerbations of COPD was evaluated by measuring adherence to current guideline recommendations and examining the impact of hospital and patient characteristics on composite measures of performance.
Research opportunities in the management of acute exacerbations of chronic obstructive pulmonary disease.
TLDR
The utility and performance characteristics of diagnostic testing need to be determined for this difficult patient population and it remains unclear which patient-specific therapies should be used and monitored.
Management of chronic obstructive pulmonary disease exacerbations in Internal Medicine
TLDR
To improve the management of COPD exacerbations, the focus of care must be shifted from the episodic acute complications to their systematic prevention, and a wide range of therapeutic available options are provided.
Review of Guidelines and the Literature in the Treatment of Acute Bronchospasm in Chronic Obstructive Pulmonary Disease
TLDR
Prevention strategies have been developed for acute exacerbations, and management strategies include using short‐acting β2‐agonists, systemic corticosteroids, and antibiotics, in both at‐home and hospital settings.
Management of chronic obstructive pulmonary disease: the Swiss guidelines. Official Guidelines of the Swiss Respiratory Society.
TLDR
These new guidelines are based on those published in 1997, the GOLD report, a collaborative project of the U.S. National Heart, Lung and Blood Institute and the World Health Organisation, and an extensive review of the pertinent literature.
Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?
TLDR
There is an urgent need for the design of appropriate multicentric studies to define the usefulness of antibiotics in acute exacerbations of chronic bronchitis and the impact of antibiotic therapy on the development of bacterial resistance.
Clinical research in chronic obstructive pulmonary disease: needs and opportunities.
Chronic obstructive pulmonary disease (COPD) is a common condition, and one difficult to manage. Available treatments, other than smoking cessation, are only minimally effective, and the knowledge
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 132 REFERENCES
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.
TLDR
The guidelines are intended for use by physicians involved in the care of patients with COPD, and their main goals are to inform health professionals and to reverse a widespread nihilistic approach to the management of these patients.
Acute exacerbation of COPD: factors associated with poor treatment outcome.
TLDR
The results of this study suggest that patient host factors and not antibiotic choice may determine treatment outcome, and prospective studies in appropriately stratified patients are needed to validate these findings.
Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
TLDR
Treatment with systemic glucocorticoids results in moderate improvement in clinical outcomes among patients hospitalized for exacerbations of COPD, and the maximal benefit is obtained during the first two weeks of therapy.
Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group.
TLDR
It is concluded that FEV(1) measurements at admission and over the first several days of hospitalization are highly predictive of clinical outcomes during exacerbations of COPD.
Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments)
TLDR
Patients and caregivers should be aware of the likelihood of poor outcomes following hospitalization for exacerbation of COPD associated with hypercarbia, and are advised to report a good, very good, or excellent quality of life.
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis.
TLDR
A meta-analysis of randomized trials was performed to estimate the effectiveness of antibiotics in treating exacerbations of chronic obstructive pulmonary disease, suggesting a small but statistically significant improvement due to antibiotic therapy in patients with exacerbation of COPD.
Acute exacerbations of chronic obstructive pulmonary disease and mechanical ventilation: a reevaluation.
TLDR
ICU admission of severely ill chronic obstructive pulmonary disease patients results in acceptable outcomes, and survival of < or =2 yrs is not affected by mechanical ventilation or tracheostomy requirement.
Controlled trial of oral prednisone in outpatients with acute COPD exacerbation.
TLDR
Outpatient treatment of acute COPD exacerbation with prednisone accelerates recovery of PaO2, A-aDO2, FEV1, and PEF, reduces the treatment failure rate, and improves subjective dyspnea.
...
1
2
3
4
5
...